| Gene Therapies for Inherited Retinal Diseases | Callie DENG, Cagri G. BESİRLİ | 115–122 |
| Comparison of Visual and Anatomical Outcomes of Half Fluence - Full Dose and Half Dose - Full Fluence Photodynamic Therapy in Eyes with Chronic Central Serous Chorioretinopathy | Buğra KARASU,Özüm YÜCEL | 123–130 |
| Outcomes of Surgical Treatment in Cases with Submacular Hemorrhage | Aslı Kırmacı KAKABKCI,Gürkan ERDOĞAN,Burcu KEMER ATİK,İrfan PERENTE | 131–138 |
| The Evaluation of Retinal Non-perfusion with Multicolor Imaging in Diabetic Retinopathy | Yüksel SÜLLÜ, Serife Gülhan KONUK, Özlem ESKİ YÜCEL, Hilal Eser Öztürk | 139–145 |
| Comparison of Dose-Related Isotretinoin Effects on SD-OCT Parameters in Patients with Acne Vulgaris | Ümran GÜNAY, Burak TANYILDIZ, Hatice Selen KANAR | 146–151 |
| Intravitreal Dexamethasone Implant Treatment in Patients With Diabetic Macular Edema Resistant to Anti-VEGF Treatment | Haşim USLU, Ayşe Yağmur KANRA, Meltem Güzin ALTINEL | 152–157 |
| Short-term Vitreoretinal Tamponade with Perfluorodecalin for Retinal Detachment | Emrah ÖZTÜRK, Abuzer GÜNDÜZ, Ercan ÖZSOY, Yakup YILDIZLI | 158–162 |
| Evaluating the Refraction Results of Patients who had Combined Phacoemulsification-pars Plana Vitrectomy and Internal Limiting Membrane Peeling for Idiopathic Macular hole or Idiopathic Epiretinal Membrane | Hakan BAYBORA | 163–166 |
| Torpedo Maculopathy; Clinical and Imaging Findings | Mehmet Yasin TEKE, Selda ÇELİK DÜLGER | 167–172 |
| Evaluation of Retinal Vessel Diameter Measurement in Coronary Artery Disease | Şaban KELEŞOĞLU, Yener YILDIRIM, Cemal ÖZSAYGILI | 173–181 |
| Association of ARMS2 gene rs10490924 and HTRA1 gene rs11200638 Polymorphisms with Exudative Age-Related Macular Degeneration in Western Aegean Population of Turkey | Haluk AKIN, Cihangir ÖZKINAY, Serhad NALÇACI, Filiz HAZAN, Filiz AFRASHİ, Gülçin ITIRH, Jale MENTEŞ, Tansu ERAKGÜN | 182–186 |
| Macular Hole After Commercially Available Handheld Diod Laser Exposure |